analyst
CG
NASDAQ · CGEM
Cullinan Therapeutics, Inc.
Healthcare · Medical - Pharmaceuticals
$20.63
Up+$0.09 (+0.44%)
Updated Sep 17, 2026, 7:40 AM
SID Score
6.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 730.18M
- P/E ratio
- -3.35
- Dividend yield
- 0.00%
- 52-week range
- $11.68 – $23.19
- Volume
- 825.81K
- Avg. volume
- 1.2M
Price performance
CGEM price history
1M range · 20 trading sessions · Daily adjusted prices
CGEM closed at $20.63 after 20 trading sessions, down 8.39% for the selected period.
- Last close
- $20.63
- Period change
- -8.39%
- Period low
- $20.40
- Period high
- $22.95
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $20.50 | $20.84 | $20.195 | $20.63 | 825.81K |
| Sep 15, 2026 | $20.38 | $20.705 | $19.64 | $20.54 | 1.06M |
| Sep 14, 2026 | $18.55 | $20.93 | $18.51 | $20.40 | 1.42M |
| Sep 11, 2026 | $21.16 | $21.34 | $20.10 | $20.59 | 1.09M |
| Sep 10, 2026 | $20.99 | $21.215 | $20.495 | $21.00 | 805.67K |
| Sep 9, 2026 | $21.30 | $21.795 | $21.08 | $21.31 | 1.28M |
| Sep 8, 2026 | $21.61 | $22.4101 | $21.28 | $21.69 | 953.74K |
| Sep 4, 2026 | $21.88 | $22.30 | $21.77 | $22.09 | 562.49K |
| Sep 3, 2026 | $22.39 | $22.68 | $21.65 | $22.16 | 524.12K |
| Sep 2, 2026 | $21.88 | $22.79 | $21.75 | $22.33 | 769.69K |
| Sep 1, 2026 | $21.80 | $22.07 | $21.55 | $21.79 | 546.14K |
| Aug 31, 2026 | $21.50 | $22.23 | $21.34 | $22.07 | 682.98K |
| Aug 28, 2026 | $22.60 | $22.88 | $21.565 | $21.70 | 630.09K |
| Aug 27, 2026 | $22.55 | $22.958 | $22.185 | $22.60 | 471.91K |
| Aug 26, 2026 | $22.66 | $23.19 | $22.42 | $22.85 | 683.47K |
| Aug 25, 2026 | $22.16 | $23.06 | $22.155 | $22.95 | 519.26K |
| Aug 24, 2026 | $21.62 | $22.3699 | $21.1564 | $21.82 | 617.37K |
| Aug 21, 2026 | $21.72 | $22.11 | $21.40 | $21.68 | 758.22K |
| Aug 20, 2026 | $22.14 | $22.25 | $21.02 | $21.38 | 902.53K |
| Aug 19, 2026 | $21.48 | $22.54 | $21.2201 | $22.52 | 707.19K |
Latest CGEM news
The latest Smart Investors Daily articles mentioning CGEM.
Stock researchResearch & News · SEC Filings
Loading stock research…